Literature DB >> 9106189

Characterisation of the binding sites of monoclonal antibodies reacting with the Plasmodium falciparum rhoptry protein RhopH3.

J C Doury1, J L Goasdoue, H Tolou, M Martelloni, S Bonnefoy, O Mercereau-Puijalon.   

Abstract

Twenty one mouse monoclonal antibodies reacting or cross-reacting with the Plasmodium falciparum RhopH3 protein reacted with Ag44, a recombinant antigen expressing the 134 C-terminal RhopH3 residues. Using overlapping peptides scanning this region, two major binding sites were identified. The first one, recognised by eight anti-RhopH3 and seven cross-reacting mAbs, was mapped to the sequence Thr Asp Asn Thr Tyr or Thr Asp Asn Thr Tyr Lys (aa 823-828), depending on the support used for synthesis. Binding specificity and affinity were investigated for a subset of four mAbs reacting with this epitope, including one growth inhibitory mAb. Systematic replacements showed that the various mAbs had similar requirements. The inhibitory mAb presented a higher affinity for this sequence and bound to the adjacent sequence, Tyr Lys Glu Met Glu Leu (aa 827-832). A 2nd binding site, located around residue 850, was recognised by two anti-RhopH3 mAbs, which reacted exclusively with the 110 kDa RhopH3 polypeptide, unlike the other mAbs, which reacted with the 110 and 105 kDa RhopH3 antigens. This suggested that the 105 kDa RhopH3 polypeptide derives from the 110 kDa by C-terminal processing. Experimental evidence substantiating this conclusion was provided by the observation that antisera raised to peptides located upstream of the putative cleavage site reacted with both the 110 kDa and 105 kDa polypeptides, whereas antisera raised to the 45 C-terminal amino acids of RhopH3 reacted exclusively with the larger, 110 kDa product. The biological significance of this processing is discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9106189     DOI: 10.1016/s0166-6851(96)02819-8

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  7 in total

1.  Recombinant antibodies specific for the Plasmodium falciparum histidine-rich protein 2.

Authors:  Elisabeth Ravaoarisoa; Halima Zamanka; Thierry Fusai; Jacques Bellalou; Hugues Bedouelle; Odile Mercereau-Puijalon; Thierry Fandeur
Journal:  MAbs       Date:  2010-07-01       Impact factor: 5.857

2.  Functional diversification between two related Plasmodium falciparum merozoite invasion ligands is determined by changes in the cytoplasmic domain.

Authors:  Jeffrey D Dvorin; Amy K Bei; Bradley I Coleman; Manoj T Duraisingh
Journal:  Mol Microbiol       Date:  2010-02       Impact factor: 3.501

3.  Suggestive evidence for Darwinian Selection against asparagine-linked glycans of Plasmodium falciparum and Toxoplasma gondii.

Authors:  G Guy Bushkin; Daniel M Ratner; Jike Cui; Sulagna Banerjee; Manoj T Duraisingh; Cameron V Jennings; Jeffrey D Dvorin; Marc-Jan Gubbels; Seth D Robertson; Martin Steffen; Barry R O'Keefe; Phillips W Robbins; John Samuelson
Journal:  Eukaryot Cell       Date:  2009-09-25

4.  Identification of Plasmodium falciparum RhopH3 protein peptides that specifically bind to erythrocytes and inhibit merozoite invasion.

Authors:  Carlos Giovanni Pinzón; Hernando Curtidor; Claudia Reyes; David Méndez; Manuel Elkin Patarroyo
Journal:  Protein Sci       Date:  2008-07-01       Impact factor: 6.725

5.  Associations between responses to the rhoptry-associated membrane antigen of Plasmodium falciparum and immunity to malaria infection.

Authors:  Agnieszka E Topolska; Thomas L Richie; Doan Hanh Nhan; Ross L Coppel
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

6.  An essential contractile ring protein controls cell division in Plasmodium falciparum.

Authors:  Rachel M Rudlaff; Stephan Kraemer; Vincent A Streva; Jeffrey D Dvorin
Journal:  Nat Commun       Date:  2019-05-16       Impact factor: 14.919

7.  Phosphorylation of Rhoptry Protein RhopH3 Is Critical for Host Cell Invasion by the Malaria Parasite.

Authors:  Roseleen Ekka; Ankit Gupta; Sonika Bhatnagar; Pawan Malhotra; Pushkar Sharma
Journal:  mBio       Date:  2020-10-06       Impact factor: 7.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.